Sensus scores Premier contract for brachytherapy

Superficial radiation therapy provider Sensus Healthcare has signed a group...Read more on AuntMinnie.comRelated Reading: Sensus inks R&D pact with UPenn Sensus touts research for nonmelanoma skin cancer FDA clears Sensus Healthcare's IORT system Sensus names new VP of clinical development Sensus appoints new sales VP for oncology
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Erica S. Tarabadkar† and Michi M. Shinohara*† Division of Dermatology, University of Washington, Seattle, WA, United States Skin directed therapies (SDTs) serve important roles in the treatment of early stage cutaneous T-cell lymphoma (CTCL)/mycosis fungoides (MF), as well as managing symptoms and improving quality of life of all stages. There are now numerous options for topical therapies that demonstrate high response rates, particularly in early/limited MF. Phototherapy retains an important role in treating MF, with increasing data supporting efficacy and long-term safety of both UVB and PUVA as ...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Authors: Pashazadeh A, Boese A, Friebe M Abstract Nonmelanoma skin cancer (NMSC) is a major health concern due to its high incidence rate, its negative impact on the quality of life of patients as well as the associated economic burden to the healthcare system. Surgery is currently the primary treatment offered for skin cancer patients but not applicable or available in all cases. Radiation therapy (RT), with its long successful history in the management of cancer, has shown to be an effective alternative or complementary method in cutaneous oncology. Specifically, for dermatology applications, RT is very often the...
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
Key motivations for the development of the Clinical Specialist Radiation Therapist (CSRT) role in Ontario were to improve the quality of cancer care and maximize system efficiency. Quantifying the value or impact of each role is integral to sustainability especially in times of fiscal restraint. Our institution currently has 4 distinct CSRT roles in: brachytherapy, stereotactic body radiation therapy (SBRT), non-melanoma skin cancer and brain radiosurgery. In order to assess the value afforded by the clinical practice of each role, electronic workload codes were created to capture patient related encounters, which can subs...
Source: Journal of Medical Imaging and Radiation Sciences - Category: Radiology Authors: Source Type: research
To determine the clinical outcome of patients treated with radiation therapy for periocular nonmelanoma skin cancer (NMSC).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research
Sensus Healthcare is a medical device company that focuses on providing non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids utilizing superficial radiation technology (SRT). Their proprietary, FDA-cleared SRT technology...
Source: Medgadget - Category: Medical Devices Authors: Tags: Dermatology Exclusive Oncology Source Type: blogs
To the Editor: We wish to provide a clarification regarding the cost of electronic brachytherapy (EBT) in the treatment of skin cancer. Though published in September 2016, the original manuscript and all calculations were completed with the correct available data in June 2015.1 This was shortly after, and in response to, the publication by Kauvar et  al2 in May 2015 who reported the cost of radiation therapy at $2591 to $3460 without differentiating between hospital-based radiation oncologist–delivered radiation therapy (RT) and dermatologic office–based superficial radiation therapy (SRT).
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Tags: JAAD Online Source Type: research
CONCLUSIONS: This work is special, since the equipment's treatment voltage was 69.5 kV, and this is the first prospective study with long term follow-up with Esteya(®). These preliminary report show excellent results with less toxicity and excellent cosmesis. While surgery has been the treatment of choice, certain patients might benefit from eBT treatment. These are elderly patients with comorbidities or undergoing anticoagulant treatment as well as those who simply refuse surgery or might have other contraindications. PMID: 28725249 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Authors: Ota K, Adar T, Dover L, Khachemoune A Abstract Electronic Brachytherapy (EBT) has seen a significant rise in use over the past few years in treating non-melanoma skin cancer (NMSC). However, the current literature in EBT remains scarce. Existing data on high dose rate brachytherapy (HDR-BT) with surface applicators is often used to justify its efficacy and safety. In this review we study the two treatment modalities on their efficacy in treating NMSC and we explore the reasons behind the recent uprise in EBT. A literature review using PubMed was performed for articles published until January 2017 studying ...
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
The gold standard for treatment of early stage non-melanoma skin cancers (NMSC) is surgery. In patients with NMSC of the extremities, complications from definitive surgery, such as non-healing wounds are common due to poor blood flow, age, and comorbidities that delay healing. In situations where NMSC is located on the extremities, radiation therapy may be preferred as it does not involve surgical excision and thus may reduce the rate of non-healing wound formation. We have used a modern version of brachytherapy, the ‘3D topographic applicator brachytherapy’ (3TAB), to treat NMSC since 2010.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
To develop a novel conformal superficial brachytherapy (CSBT) device as a treatment option for the patient-specific radiation therapy of conditions including superficial lesions, postsurgical positive margins, Dupuytren's contractures, keloid scars, and complex anatomic sites (eyelids, nose, ears, etc.).
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Contracts | Nonmelanoma Skin Cancer | Radiation Therapy | Radiology | Skin | Skin Cancer